Skip to search formSkip to main contentSkip to account menu

Propranolol for severe hemangiomas of infancy.

It is observed in 11 children that propranolol can inhibit the growth of infantile capillary hemangiomas and this work is hopeful that this discovery will help improve the prognosis of these patients.
View on PubMed (opens in a new tab)

Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic.

The results suggest that chilblain-like lesions observed during the COVID-19 pandemic represent manifestations of a viral-induced type I interferonopathy.
View on PubMed (opens in a new tab)

Clinical Phenotype of Scabies by Age

There is a specific clinical presentation of scabies in infants and children that seems to vary according to age, taking into account these specificities may be helpful for the early diagnosis and the identification of cases to prevent the propagation of the disease.
View on Publisher (opens in a new tab)

Analysis of SPINK 5, KLK 7 and FLG genotypes in a French atopic dermatitis cohort.

The association of atopic dermatitis with filaggrin variants was confirmed, but not that of SPINK5 or KLK7 polymorphisms, which may modulate systemic immune effects favouring the IgE response to atopens.
View on PubMed (opens in a new tab)

Dermatological Spectrum of Hand, Foot and Mouth Disease from Classical to Generalized Exanthema

Hospitalised children with confirmed HFMD have a clinical spectrum ranging from classical to generalized vesicular exanthema, and CV-A6 is associated with peri-oral rash, which is related to coxsackie virus A6 when there is an atypical rash.
View on Wolters Kluwer (opens in a new tab)

Skin manifestations of COVID‐19 in children: Part 1

This review summarizes the current knowledge on the cutaneous manifestations of COVID‐19 in children after thorough and critical review of articles published in the literature and from the personal experience of a large panel of paediatric dermatologists in Europe.
View on Wiley (opens in a new tab)

Anti‐PD1‐induced psoriasis: a study of 21 patients

Nivolumab is licensed in advanced melanoma and second-line therapy of advanced or metastatic non-small cell lung cancer, and pembrolizumab (Keytruda®), atezolIZumab, and pidilizumABab are anti-PD1 monoclonal antibodies.
View on Wiley (opens in a new tab)

Epicutaneous aeroallergen sensitization in atopic dermatitis infants – determining the role of epidermal barrier impairment

This work has shown that early epidermal barrier impairment may facilitate the epicutaneous penetration of atopens.
View on Wiley (opens in a new tab)

Pericyte alteration sheds light on micro-vasculopathy in COVID-19 infection

View on Springer (opens in a new tab)

Skin manifestations of COVID‐19 in children: Part 2

This review summarizes the current knowledge on the cutaneous manifestations of COVID‐19 in children after thorough and critical review of articles published in the literature and from the personal experience of a large panel of paediatric dermatologists in Europe.
View on Wiley (opens in a new tab)
...
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)